Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20606544 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Effectiveness of Rituximab in Pediatric OMS Patients.
Conditions: Opsoclonus-myoclonus Syndrome;   Opsoclonus;   Myoclonus;   Ataxia
Intervention: Drug: rituximab

Study has passed its completion date and status has not been verified in more than two years.